4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury

[1]  R. Shi,et al.  Dose responses of three 4-aminopyridine derivatives on axonal conduction in spinal cord trauma. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  R. Shi,et al.  Development of novel 4-aminopyridine derivatives as potential treatments for neurological injury and disease. , 2005, European journal of medicinal chemistry.

[3]  M. Rasband.  It's “juxta” potassium channel! , 2004, Journal of neuroscience research.

[4]  M. Fehlings,et al.  Temporal and spatial patterns of Kv1.1 and Kv1.2 protein and gene expression in spinal cord white matter after acute and chronic spinal cord injury in rats: implications for axonal pathophysiology after neurotrauma , 2004, The European journal of neuroscience.

[5]  J. Hsieh,et al.  Pharmacokinetics and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury. , 2004, Archives of physical medicine and rehabilitation.

[6]  R. Shi,et al.  Effects of 4-aminopyridine on stretched mammalian spinal cord: the role of potassium channels in axonal conduction. , 2003, Journal of neurophysiology.

[7]  Rational modelling of the voltage-dependent K+ channel inactivation by aminopyridines. , 2003, Biophysical chemistry.

[8]  R. Shi,et al.  Pathological changes of isolated spinal cord axons in response to mechanical stretch , 2002, Neuroscience.

[9]  D F Meaney,et al.  Dynamic stretch correlates to both morphological abnormalities and electrophysiological impairment in a model of traumatic axonal injury. , 2001, Journal of neurotrauma.

[10]  J. Trimmer,et al.  Subunit composition and novel localization of K+ channels in spinal cord , 2001, The Journal of comparative neurology.

[11]  A. Blight,et al.  Intrathecal administration of 4-aminopyridine in chronic spinal injured patients , 2000, Spinal Cord.

[12]  F. Peña,et al.  Seizures and neurodegeneration induced by 4-aminopyridine in rat hippocampus in vivo: role of glutamate- and GABA-mediated neurotransmission and of ion channels , 2000, Neuroscience.

[13]  A. Blight,et al.  Intravenous infusion of 4-AP in chronic spinal cord injured subjects , 2000, Spinal Cord.

[14]  John A. Wolf,et al.  High Tolerance and Delayed Elastic Response of Cultured Axons to Dynamic Stretch Injury , 1999, The Journal of Neuroscience.

[15]  F. Peña,et al.  Relationships Among Seizures, Extracellular Amino Acid Changes, and Neurodegeneration Induced by 4‐Aminopyridine in Rat Hippocampus: A Microdialysis and Electroencephalographic Study , 1999, Journal of neurochemistry.

[16]  R B Borgens,et al.  Acute repair of crushed guinea pig spinal cord by polyethylene glycol. , 1999, Journal of neurophysiology.

[17]  B. Kakulas,et al.  A review of the neuropathology of human spinal cord injury with emphasis on special features. , 1999, The journal of spinal cord medicine.

[18]  J. Hsieh,et al.  Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury. , 1998, Journal of neurotrauma.

[19]  T. M. Kelly,et al.  Conduction Block in Acute and Chronic Spinal Cord Injury: Different Dose–Response Characteristics for Reversal by 4-Aminopyridine , 1997, Experimental Neurology.

[20]  B. Kakulas,et al.  Neuropathology of human spinal cord injury sustained in sports-related activities. , 1997, Journal of neurotrauma.

[21]  A. Blight,et al.  Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord , 1997, Neuroscience.

[22]  A. Blight,et al.  Compression injury of mammalian spinal cord in vitro and the dynamics of action potential conduction failure. , 1996, Journal of neurophysiology.

[23]  M. Fehlings,et al.  The relationships among the severity of spinal cord injury, residual neurological function, axon counts, and counts of retrogradely labeled neurons after experimental spinal cord injury , 1995, Experimental Neurology.

[24]  B. Robertson,et al.  On the mechanism of 4‐aminopyridine action on the cloned mouse brain potassium channel mKv1.1. , 1994, The Journal of physiology.

[25]  D. Wolfe,et al.  4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury. , 1994, Journal of neurotrauma.

[26]  R. Hoffman,et al.  Characterization of 4-aminopyridine in overdose. , 1994, Journal of Toxicology Clinical Toxicology.

[27]  A. Blight,et al.  4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients. , 1993, Journal of neurotrauma.

[28]  T A Gennarelli,et al.  Focal axonal injury: the early axonal response to stretch , 1991, Journal of neurocytology.

[29]  A. Blight,et al.  The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial. , 1991, Journal of neurotrauma.

[30]  A. Blight.  Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury , 1989, Brain Research Bulletin.

[31]  J. A. Gruner,et al.  Augmentation by 4-aminopyridine of vestibulospinal free fall responses in chronic spinal-injured cats , 1987, Journal of the Neurological Sciences.

[32]  A. Blight,et al.  Morphometric analysis of experimental spinal cord injury in the cat: The relation of injury intensity to survival of myelinated axons , 1986, Neuroscience.

[33]  J. Kocsis,et al.  Action potential characteristics of demyelinated rat sciatic nerve following application of 4-aminopyridine , 1986, Brain Research.

[34]  A. Blight,et al.  Computer simulation of action potentials and afterpotentials in mammalian myelinated axons: The case for a lower resistance myelin sheath , 1985, Neuroscience.

[35]  Elisabeth F. Targ,et al.  4-aminopyridine leads to restoration of conduction in demyelinated rat sciatic nerve , 1985, Brain Research.

[36]  A. Blight.  Axonal physiology of chronic spinal cord injury in the cat: Intracellular recording in vitro , 1983, Neuroscience.

[37]  A. Blight,et al.  Cellular morphology of chronic spinal cord injury in the cat: Analysis of myelinated axons by line-sampling , 1983, Neuroscience.

[38]  T. Narahashi,et al.  Site of action and active form of aminopyridines in squid axon membranes. , 1983, The Journal of pharmacology and experimental therapeutics.

[39]  T A Sears,et al.  The effects of 4‐aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres. , 1981, The Journal of physiology.

[40]  J. M. Ritchie,et al.  Potassium channels in nodal and internodal axonal membrane of mammalian myelinated fibres , 1980, Nature.

[41]  H. Bostock,et al.  Effects of 4-aminopyridine on normal and demyelinated mammalian nerve fibres , 1980, Nature.